What Fueled The Previous Growth In The Bone Growth Stimulator Market?
The bone growth stimulator market has shown significant expansion over recent years, owing to numerous contributory factors.
• The market size was valued at $1.65 billion in 2024 and increased to $1.82 billion in 2025, marking a robust compound annual growth rate (CAGR) of 10.0%.
The aging population, a surge in orthopedic conditions, heightened awareness around non-invasive treatments, expansion of healthcare access, and an inclusive reimbursement policy environment have primarily driven this growth. Moreover, the increased prevalence of orthopedic surgeries and rising demand for minimally invasive solutions have also boosted the market.
What Is The Expected Growth In The Bone Growth Stimulator Market Size?
The bone growth stimulator market is poised for a rapid upswing in the coming years.
• Forecasts project the market will reach a valuation of $2.66 billion by 2029, with a CAGR of 10.0%.
Factors contributing to this anticipated growth include public awareness, adoption of regenerative medicine, investments in healthcare infrastructure, expanding applications, and favorable healthcare policies. Key trends shaping the future of the market include advancements in regenerative medicine, 3D printing technology, wireless technologies for remote patient monitoring, patient-centric care, and telemedicine.
What Are The Key Drivers Of The Bone Growth Stimulator Market?
The surge in bone fractures greatly impact the bone growth stimulator market. Age, diet, and chronic disorders can weaken bones and repetitive motions can lead to fractures. For instance, the U.S. biotech firm, Amgen, reported in May 2022 that due to osteoporosis, about 1.5 million fractures were recorded annually in the United States, resulting in $19 billion in associated costs. Furthermore, forecasts predict an annual increase of 68% in osteoporotic fractures from 1.9 million to 3.2 million between 2018 and 2040.
What Are The Market Segments In The Bone Growth Stimulator Market?
The bone growth stimulator market segmentation includes –
1) By Type: Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP) Therapy
2) By Type Of Use: Implantable Device, External Device
3) By Application: Fractures, Spinal Fusion, Osteogenesis, Arthrodesis Treatment, Spondylolisthesis
4) By End User: Hospitals & ASCs, Specialty Clinics, Home Care
Pre-Book The Bone Growth Stimulator Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights Here:
What Trends Are Shaping The Bone Growth Stimulator Market?
Technological advancements are a prominent trend shaping the bone growth stimulator market. For instance, in May 2022, Orthofix Medical Inc., a US-based firm, received FDA pre-market approval for the AccelStim bone healing therapy, a non-surgical treatment for fractures. The device delivers a Low-Intensity Pulsed Ultrasound (LIPUS) signal to boost the bone's natural healing.
Who Are The Key Players In The Bone Growth Stimulator Market?
Leading market players include:
• Arthrex Inc.
• DJO Global Inc.
• Stryker Corporation
• Bioventus LLC
• Zimmer Biomet Holdings Inc.
• 3M Company
• Becton Dickinson and Company
• Cognionics Inc.
• ConMed Corporation
• The Cooper Companies Inc.
What Is The Current Regional Market Landscape Of The Bone Growth Stimulator Market?
In 2024, North America stood as the largest market for the bone growth stimulator industry. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period, encompassing a broad spectrum of markets including Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
